Population Health Management / Healthcare Services
Strategic Profile
P3's extensive experience managing Medicare Advantage populations in global risk arrangements drives its differentiated model, which simultaneously improves care and decreases costs. Expansion in the Medicare market and shift to value-based care models position the company for sustained membership and revenue growth, while strong payer relationships and expanding joint ventures support higher, recurring revenue and significant market share gains.
Cyborg Score Rationale
The company has a market cap of $734.573M but reported negative EPS of -57.16 (TTM), indicating current unprofitability despite strong market positioning. Technology investments, operational efficiencies, and stronger payer collaborations are creating measurable cost savings and margin expansion opportunities. The company faces execution risks while pursuing growth in the expanding Medicare Advantage market.
Top Insights
Substantial market opportunity to partner with physicians and payors that serve the 60 million estimated Medicare eligible beneficiaries in the $300 billion Medicare Advantage Market.
The partnership approach has resulted in 99% physician retention, evidence that the company is effectively empowering providers.
P3 Health Partners reported Q2 2025 earnings with revenue of $356 million, surpassing analyst forecasts of $349.73 million.
Stock currently trading at $3.62, down significantly from 52-week high of $14.50, reflecting recent market challenges.
Named Competitors
Medicare Advantage Management — Population health and Medicare Advantage services
Primary Care Networks — Medicare Advantage and primary care services
Specialty Oncology Management — Specialty cancer care services
Physician Services Platform — Healthcare services and staffing
Recent Developments
(September 2025) P3 Health Partners presented at IAccess Alpha Virtual Best Ideas Fall Conference
(June 2025) Company announced appointment of Dr. Aric Coffman as Chief Executive Officer and entered significant financing transaction with VBC Growth SPV 5, LLC